-+ 0.00%
-+ 0.00%
-+ 0.00%

Earnings Update: Nufarm Limited (ASX:NUF) Just Reported And Analysts Are Trimming Their Forecasts

Simply Wall St·11/20/2026 20:07:42
Listen to the news

It's shaping up to be a tough period for Nufarm Limited (ASX:NUF), which a week ago released some disappointing full-year results that could have a notable impact on how the market views the stock. It was a pretty negative result overall, with revenues of AU$3.2b missing analyst predictions by 2.3%. Additionally, the business reported a statutory loss of AU$0.26 per share, larger than the analysts had forecast prior to the result. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

earnings-and-revenue-growth
ASX:NUF Earnings and Revenue Growth November 20th 2026

Taking into account the latest results, Nufarm's eight analysts currently expect revenues in 2027 to be AU$3.19b, approximately in line with the last 12 months. Nufarm is also expected to turn profitable, with statutory earnings of AU$0.08 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of AU$3.38b and earnings per share (EPS) of AU$0.13 in 2027. From this we can that sentiment has definitely become more bearish after the latest results, leading to lower revenue forecasts and a large cut to earnings per share estimates.

See our latest analysis for Nufarm

The analysts made no major changes to their price target of AU$3.61, suggesting the downgrades are not expected to have a long-term impact on Nufarm's valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Nufarm analyst has a price target of AU$4.14 per share, while the most pessimistic values it at AU$3.25. This is a very narrow spread of estimates, implying either that Nufarm is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would also point out that the forecast 0.6% annualised revenue decline to the end of 2027 is better than the historical trend, which saw revenues shrink 1.8% annually over the past five years By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 6.4% per year. So while a broad number of companies are forecast to grow, unfortunately Nufarm is expected to see its revenue affected worse than other companies in the industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Nufarm. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Nufarm going out to 2029, and you can see them free on our platform here.

You can also view our analysis of Nufarm's balance sheet, and whether we think Nufarm is carrying too much debt, for free on our platform here.